Form S-1/A Parabilis Medicines,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260604/A42ZT22EZZ2RP2ZU22JC2WYSHRBDZZ22ZI82
Filed on: June 4, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Columbia Financial and Northfield Bancorp mail merger election materials
- Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK
- FDA approves Lilly's EBGLYSS for eight-week dosing in atopic dermatitis
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
